Business Context and Reporting Period
Pavmed Inc., a Delaware corporation and emerging growth company, filed this Form 8-K on June 12, 2018. The report details the completion of a previously announced equity subscription rights offering.
Key Financial Metrics
- Gross Proceeds: $10,350,000
- Units Issued: 9,000,000
- Subscription Price: $1.15 per unit
- Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide a clear value for these operational metrics as this is a current report focused on a capital event.
Material Changes
The primary material change is the increase in equity capital resulting from the fully subscribed Rights Offering. The offering was completed through the exercise of Basic Subscription Rights and Over-subscription Privileges by stockholders.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future operations, or specific risk factors beyond the standard disclosures associated with the capital raise. The press release announcing the closing is incorporated by reference as Exhibit 99.1.
Investor Verification Checklist
- Verify the final use of the $10,350,000 in gross proceeds.
- Confirm the total number of outstanding shares post-issuance to assess dilution.
- Review the full text of the press release (Exhibit 99.1) for additional context on the offering.